WASINGTION — There was a bipartisan bashing of Mylan CEO Heather Bresch Wednesday over her company’s huge price increases on EpiPen, the auto-injector that delivers a drug that counters the effects of a potentially fatal allergic reaction.
In-depth journalism.
In your home state.
In your inbox.
Sign up for CT Mirror's free daily briefings.
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.